Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

MaxLinear Q1 2024 Adj EPS $(0.21) Beats $(0.22) Estimate, Sales $95.269M Beat $93.933M Estimate

Author: Benzinga Newsdesk | April 24, 2024 04:14pm
MaxLinear (NASDAQ:MXL) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.22) by 4.55 percent. This is a 128.38 percent decrease over earnings of $0.74 per share from the same period last year. The company reported quarterly sales of $95.269 million which beat the analyst consensus estimate of $93.933 million by 1.42 percent. This is a 61.65 percent decrease over sales of $248.442 million the same period last year.

Posted In: MXL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist